About this trial
This prospective randomized controlled study aims to evaluate the effects of preoperative ultrasound-guided erector spinae plane (ESP) block combined with low-flow anaesthesia on postoperative quality of recovery and opioid consumption in patients undergoing elective laparoscopic cholecystectomy. The study will compare postoperative recovery quality, pain scores, analgesic requirements, and perioperative outcomes between patients receiving ESP block with low-flow anaesthesia and those receiving standard anaesthetic management.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18-65 years
ASA physical status I-II
Body mass index (BMI) <35 kg/m²
Scheduled for elective laparoscopic cholecystectomy
Disqualifiers
Coagulopathy or bleeding disorders
Allergy to local anaesthetic agents
Infection at the block application site
Neurological or psychiatric disorders
Trial design
Parallel
Treatments tested in this trial
Erector Spinae Plane Block
Procedure/SurgeryBilateral ultrasound-guided erector spinae plane block (ESPB) will be performed preoperatively at the T7-T8 level
Low Fresh Gas Flow (0.5 L/min)
Other interventionLow-flow anaesthesia will be maintained with sevoflurane using a fresh gas flow rate of 0.5 L/min after the initial high-flow phase following induction of general anaesthesia.
Standard Fresh Gas Flow (3 L/min)
Other interventionStandard-flow anaesthesia will be maintained with sevoflurane using a fresh gas flow rate of 3 L/min throughout the maintenance phase of general anaesthesia.
Bupivacaine
DrugBupivacaine 0.25% will be administered bilaterally during ultrasound-guided erector spinae plane block at the T7-T8 level, with 20 mL injected on each side approximately 30 minutes before surgery.
Sevoflurane
DrugSevoflurane will be used as the inhalational anaesthetic agent for maintenance of general anaesthesia during elective laparoscopic cholecystectomy. The fresh gas flow rate during maintenance will be determined according to study group allocation.
Treatment groups
Trial outcomes
Primary outcomes
Quality of Recovery-15 (QoR-15) Score at Postoperative 24 Hours
Quality of Recovery-15 (QoR-15) Total Score at Postoperative 24 Hours Postoperative recovery quality will be assessed using the Quality of Recovery-15 (QoR-15) questionnaire at 24 hours after surgery. The QoR-15 is a validated patient-reported outcome measure consisting of 15 items that evaluate pain, physical comfort, emotional state, physical independence, and psychological support. Total scores range from 0 to 150, with higher scores indicating better postoperative recovery and a higher quality of recovery.
Secondary outcomes
Numeric Rating Scale (NRS) Pain Score
Postoperative pain intensity will be assessed using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Postoperative Shoulder Pain Score
The severity of postoperative shoulder pain associated with laparoscopic surgery will be assessed using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater shoulder pain severity.
Total Opioid Consumption During the First 24 Postoperative Hours
The cumulative amount of opioid analgesics administered during the first 24 postoperative hours will be recorded. Unit of Measure: microgram fentanyl
Time to First Rescue Analgesic Requirement
The time elapsed between the end of surgery and the first administration of rescue analgesic medication will be recorded. Unit of Measure: minutes
Sponsors and contacts
Click on the lead sponsor to view all of their trials.